Insider · CIK 0001230584
Michael H Carrel
directorceopresidentofficer
Files at ATRC (AtriCure, Inc.), AXNX (Axonics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | ATRC AtriCure, Inc. | GGift Common Stock | -4,000 | $0.00 | $0 | 706,555 | Mar 12, 2025 |
| Mar 1, 2025 | ATRC AtriCure, Inc. | AGrant or award Common Stock | +50,335 | $0.00 | $0 | 703,574 | Mar 4, 2025 |
| Mar 1, 2025 | ATRC AtriCure, Inc. | AGrant or award Common Stock | +50,907 | $0.00 | $0 | 754,481 | Mar 4, 2025 |
| Mar 1, 2025 | ATRC AtriCure, Inc. | FTax withholding Common Stock | -43,926 | $38.74 | $1.7M | 710,555 | Mar 4, 2025 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Common Stock | -17,861 | $71.00 | $1.3M | 0 | Nov 15, 2024 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | $36.90 | $185k | 0 | Nov 15, 2024 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | $50.15 | $502k | 0 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.